Goldman Sachs Group Inc Kiora Pharmaceuticals Inc Transaction History

Goldman Sachs Group Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$0.36 - $0.68 $4,779 - $9,027	-13,275 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.54 - $1.27 $7,168 - $16,859	13,275 New	13,275 $8,000

Ticker KPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 919,078
Market Cap $3.43M
Description
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.